TABLE 1.
Demographic characteristics before and after propensity-score matching*.
Variable | All patients | Propensity-matched sample | ||||
|
|
|||||
DCB group (n = 251) |
DES group (n = 792) |
P-value | DCB group (n = 199) |
DES group (n = 398) |
P-value | |
Age (years) | 61.28 ± 11.14 | 63.91 ± 7.76 | 0.001 | 63.75 ± 8.13 | 64.48 ± 7.75 | 0.261 |
Sex (Male) | 188 (74.90%) | 586 (73.99%) | 0.774 | 145 (72.86%) | 299 (75.13%) | 0.551 |
Comorbidity | ||||||
Diabetes mellitus | 96 (38.25%) | 299 (37.75%) | 0.888 | 77 (38.69%) | 165 (41.46%) | 0.517 |
Hypertension | 125 (49.80%) | 399 (50.38%) | 0.873 | 107 (53.77%) | 205 (51.51%) | 0.602 |
Hyperlipidemia | 63 (25.10%) | 241 (30.43%) | 0.105 | 54 (27.14%) | 119 (29.90%) | 0.483 |
History of smoking | 89 (35.46%) | 295 (37.25%) | 0.609 | 72 (36.18%) | 138 (34.67%) | 0.716 |
Renal insufficiency | 9 (3.59%) | 61 (7.70%) | 0.023 | 7 (3.52%) | 24 (6.03%) | 0.192 |
Clinical presentation | 0.433 | 0.478 | ||||
Stable angina | 91 (36.25%) | 309 (39.02%) | 75 (37.69%) | 162 (40.70%) | ||
Unstable angina | 160 (63.75%) | 483 (60.98%) | 124 (62.31%) | 236 (59.30%) | ||
Previous MI history | 15 (5.98%) | 56 (7.07%) | 0.549 | 11 (5.53%) | 26 (6.53%) | 0.631 |
Previous PCI history | 42 (16.73%) | 138 (17.42%) | 0.801 | 31 (15.58%) | 74 (18.59%) | 0.362 |
Previous CABG history | 4 (1.59%) | 10 (1.26%) | 0.691 | 3 (1.51%) | 7 (1.76%) | 0.822 |
Family history of CAD | 52 (20.72%) | 188 (23.74%) | 0.322 | 43 (21.61%) | 90 (22.61%) | 0.781 |
LVEF | 59.59 ± 5.78 | 58.27 ± 6.15 | 0.005 | 59.64 ± 5.21 | 59.38 ± 5.60 | 0.941 |
*Plus–minus values are means ± SD. DCB, drug-coated balloon; DES, drug-eluting stent; MI, myocardial infarction; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting; CAD, coronary artery disease; LVEF, left ventricular ejection fraction; DES, drug-eluting stent.